Cargando…
An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
Alopecia areata is a common autoimmune disease, with a negative impact in health‐related quality of life, especially when affecting children and adolescents. Current medical therapies, mainly for severe disease, are not effective. There are no FDA (Food and Drug Administration)‐ or ANVISA (Agência N...
Autores principales: | Berbert Ferreira, Rachel, Ferreira, Sineida Berbert, Scheinberg, Morton Aaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935663/ https://www.ncbi.nlm.nih.gov/pubmed/31893096 http://dx.doi.org/10.1002/ccr3.2484 |
Ejemplares similares
-
Topical tofacitinib in treatment of alopecia areata
por: Ferreira, Sineida Berbert, et al.
Publicado: (2020) -
Remarkable Improvement of Nail Changes in Alopecia Areata Universalis with 10 Months of Treatment with Tofacitinib: A Case Report
por: Ferreira, Sineida Berbert, et al.
Publicado: (2016) -
Atopic dermatitis: Tofacitinib, an option for refractory disease
por: Berbert Ferreira, Sineida, et al.
Publicado: (2020) -
Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
por: Scheinberg, Morton, et al.
Publicado: (2017) -
Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient
por: Berbert Ferreira, Sineida, et al.
Publicado: (2021)